Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels

Policy A56161 is an administrative response to comments on MolDX Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (related LCD DL37348), recording the comment period (06/21/2017–08/04/2017), notice period (10/18/2018–12/02/2018), and LCD finalization date (12/03/2018). The document contains no clinical indications, limitations, documentation requirements, or frequency limits; consult the final LCD DL37348 for any clinical coverage criteria.

"Administrative notice: response to comments for MolDX Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (related LCD DL37348); provides comment, notice, and LCD finalization dates..."

Sign up to see full coverage criteria, indications, and limitations.